Bispecific Antibody Pipeline Congress Cancelled

In light of evolving updates and concerns around the coronavirus, we have made the difficult decision to cancel the Bispecific Antibody Pipeline Congress.

This event has always been a great opportunity to bring the bispecific therapeutics community together and advance the field. We are so disappointed to have to make this call, but feel it is the best way to move forward. We thank all of our stakeholders for their support in these uncertain times, and hope to work with all of you again in the future.

Welcome to The Bispecific Antibody Pipeline Congress

Bispecific Antibody Pipeline Congress will unite all the key opinion leaders including regulators, clinicians, and industry experts to deepen our understanding of bispecific therapeutics and exchange innovative ideas to foster meaningful research collaborations. Our 3-day bispecific-focused meeting emphasizes new and unpublished insights that are not widely shared in the scientific community.

Join your peers to discuss platform designs, execution strategies, and share safety data to maximize clinical performance of your candidates in an intimate setting which encourages close interactions and exchange of information.

CORPORATE SPONSORS